Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
-2.4%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$46.6B
AUM Growth
+$252M
(+0.54%)
Cap. Flow
+$1.72B
Cap. Flow
% of AUM
3.69%
Top 10 Holdings %
Top 10 Hldgs %
24.5%
Holding
2,693
New
484
Increased
604
Reduced
645
Closed
636
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.85B |
| 2 |
Humana
HUM
|
+$493M |
| 3 |
Kenvue
KVUE
|
+$466M |
| 4 |
AbbVie
ABBV
|
+$448M |
| 5 |
Microsoft
MSFT
|
+$367M |
Top Sells
| 1 |
Amazon
AMZN
|
+$709M |
| 2 |
Apple
AAPL
|
+$528M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$479M |
| 4 |
McKesson
MCK
|
+$358M |
| 5 |
Intel
INTC
|
+$306M |
Sector Composition
| 1 | Technology | 20.98% |
| 2 | Healthcare | 18.01% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Consumer Staples | 7.98% |
| 5 | Financials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Invesco S&P 500 Momentum ETF
SPMO
$12.6B
| $223K | ﹤0.01% |
+3,890
| New | +$223K |
|
1627
Digi International
DGII
$1.34B
| $222K | ﹤0.01% |
+8,223
| New | +$222K |
|
1628
ChargePoint
CHPT
$245M
| $222K | ﹤0.01% |
2,230
-6,394
| -74% | -$636K |
|
|
TPIC
1629
DELISTED
TPI Composites
TPIC
| $219K | ﹤0.01% |
82,678
-7,122
| -8% | -$18.9K |
|
1630
iShares ESG Advanced MSCI USA ETF
USXF
$1.29B
| $218K | ﹤0.01% |
+6,300
| New | +$218K |
|
1631
American Vanguard Corp
AVD
$160M
| $217K | ﹤0.01% |
+19,891
| New | +$217K |
|
1632
Ryan Specialty Holdings
RYAN
$6.61B
| $212K | ﹤0.01% |
+4,372
| New | +$212K |
|
1633
Adicet Bio
ACET
$66.9M
| $209K | ﹤0.01% |
+152,508
| New | +$209K |
|
|
DX
1634
Dynex Capital
DX
$1.63B
| $209K | ﹤0.01% |
+17,481
| New | +$209K |
|
1635
Global X MSCI Greece ETF
GREK
$312M
| $209K | ﹤0.01% |
6,277
-5,080
| -45% | -$169K |
|
|
PNT
1636
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $206K | ﹤0.01% |
30,958
-70,009
| -69% | -$467K |
|
1637
Third Coast Bancshares
TCBX
$549M
| $206K | ﹤0.01% |
12,061
-13,167
| -52% | -$225K |
|
|
SMMF
1638
DELISTED
Summit Financial Group, Inc.
SMMF
| $206K | ﹤0.01% |
+9,134
| New | +$206K |
|
1639
Zeta Global
ZETA
$4.8B
| $205K | ﹤0.01% |
24,500
-102,150
| -81% | -$853K |
|
|
VLRS
1640
Controladora Vuela Compañía de Aviación
VLRS
$704M
| $204K | ﹤0.01% |
30,018
| – | – |
|
1641
NewtekOne
NEWT
$305M
| $204K | ﹤0.01% |
13,802
-5,599
| -29% | -$82.6K |
|
|
THRN
1642
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $203K | ﹤0.01% |
+19,900
| New | +$203K |
|
1643
Mersana Therapeutics
MRSN
$36.5M
| $200K | ﹤0.01% |
6,312
-102,140
| -94% | -$3.24M |
|
1644
Dyne Therapeutics
DYN
$1.92B
| $198K | ﹤0.01% |
22,052
| – | – |
|
1645
Acco Brands
ACCO
$364M
| $196K | ﹤0.01% |
34,145
-14,175
| -29% | -$81.4K |
|
1646
Avita Medical
RCEL
$121M
| $196K | ﹤0.01% |
13,406
-12,094
| -47% | -$177K |
|
1647
Melco Resorts & Entertainment
MLCO
$3.74B
| $196K | ﹤0.01% |
+19,800
| New | +$196K |
|
1648
Microvast
MVST
$1.04B
| $193K | ﹤0.01% |
+102,027
| New | +$193K |
|
1649
Aurinia Pharmaceuticals
AUPH
$1.66B
| $190K | ﹤0.01% |
+24,506
| New | +$190K |
|
1650
Openlane
KAR
$3.12B
| $189K | ﹤0.01% |
12,700
-13,100
| -51% | -$195K |
|